Marc Evans

7.5k total citations · 2 hit papers
183 papers, 5.5k citations indexed

About

Marc Evans is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Molecular Biology. According to data from OpenAlex, Marc Evans has authored 183 papers receiving a total of 5.5k indexed citations (citations by other indexed papers that have themselves been cited), including 140 papers in Endocrinology, Diabetes and Metabolism, 43 papers in Surgery and 40 papers in Molecular Biology. Recurrent topics in Marc Evans's work include Diabetes Treatment and Management (106 papers), Diabetes Management and Research (72 papers) and Metabolism, Diabetes, and Cancer (38 papers). Marc Evans is often cited by papers focused on Diabetes Treatment and Management (106 papers), Diabetes Management and Research (72 papers) and Metabolism, Diabetes, and Cancer (38 papers). Marc Evans collaborates with scholars based in United Kingdom, United States and Denmark. Marc Evans's co-authors include Craig J. Currie, Chris D. Poole, David M. Williams, John R. Peters, Phil McEwan, Christopher Ll. Morgan, Asif Nawaz, Robert J. Heine, Aodán Tynan and Oswaldo L. Bracco and has published in prestigious journals such as The Lancet, Circulation and SHILAP Revista de lepidopterología.

In The Last Decade

Marc Evans

174 papers receiving 5.3k citations

Hit Papers

Survival as a function of... 2010 2026 2015 2020 2010 2021 200 400 600
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Survival as a function of HbA1c in people with type 2 diabetes: a retrospective cohort study
    2010 615 citations Craig J. Currie, Marc Evans et al. profile →
  2. A Narrative Review of Chronic Kidney Disease in Clinical Practice: Current Challenges and Future Perspectives
    2021 149 citations Marc Evans, Angharad R. Morgan et al. Advances in Therapy profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Marc Evans 3.6k 1.2k 991 875 645 183 5.5k
Richard J. MacIsaac 2.8k 0.8× 783 0.6× 882 0.9× 1.1k 1.3× 523 0.8× 227 6.9k
Dario Pitocco 2.2k 0.6× 983 0.8× 1.3k 1.3× 990 1.1× 431 0.7× 203 5.7k
Stefan Franzén 2.8k 0.8× 727 0.6× 1.2k 1.2× 1.3k 1.5× 323 0.5× 97 4.8k
Frederik Persson 3.3k 0.9× 1.2k 1.0× 991 1.0× 2.4k 2.7× 605 0.9× 182 6.3k
Samuel S. Engel 3.7k 1.0× 1.4k 1.2× 1.2k 1.2× 743 0.8× 228 0.4× 127 5.1k
David S.H. Bell 2.5k 0.7× 1.0k 0.9× 914 0.9× 1.5k 1.7× 226 0.4× 169 5.5k
Anna Norhammar 4.1k 1.2× 1.5k 1.3× 1.1k 1.1× 2.5k 2.9× 335 0.5× 133 6.1k
Tsuyoshi Watanabe 1.3k 0.4× 1.2k 1.0× 923 0.9× 1.3k 1.5× 584 0.9× 222 6.5k
Enrique Z. Fisman 1.8k 0.5× 946 0.8× 1.1k 1.1× 2.1k 2.4× 502 0.8× 165 4.9k
Eugene Manley 5.3k 1.5× 1.4k 1.2× 1.3k 1.3× 959 1.1× 200 0.3× 13 7.2k

Countries citing papers authored by Marc Evans

Since Specialization
Citations

This map shows the geographic impact of Marc Evans's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marc Evans with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marc Evans more than expected).

Fields of papers citing papers by Marc Evans

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marc Evans. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marc Evans. The network helps show where Marc Evans may publish in the future.

Co-authorship network of co-authors of Marc Evans

This figure shows the co-authorship network connecting the top 25 collaborators of Marc Evans. A scholar is included among the top collaborators of Marc Evans based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marc Evans. Marc Evans is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
McEwan, Phil, V. Foos, Geraint Roberts, et al.. (2025). Beyond glycated haemoglobin: Modelling contemporary management of type 2 diabetes with the updated Cardiff model. Diabetes Obesity and Metabolism. 27(4). 1752–1761. 1 indexed citations
2.
3.
Carter, Patrice, Rafael Simó, Monica Lövestam‐Adrian, et al.. (2025). Addressing the risk of ocular complications of GLP ‐ 1RAs ; a multi‐disciplinary expert consensus. Diabetes Obesity and Metabolism. 27(12). 7535–7543.
4.
Evans, Marc, et al.. (2025). Analysis of Tirzepatide Acquisition Costs and Weight Reduction Outcomes in the United Kingdom: Insights from the SURMOUNT-1 Study. Advances in Therapy. 42(6). 2821–2832. 2 indexed citations
5.
Edwards, Sophie, Dominic Trépel, Craig Ritchie, et al.. (2024). Real world outcomes, healthcare utilisation and costs of Alzheimer's disease in England. SHILAP Revista de lepidopterología. 4(1). 100180–100180. 3 indexed citations
6.
Finlay, A.Y., Faraz M Ali, Kennedy Otwombe, et al.. (2024). Comparison of the impact of type 1 and type 2 diabetes on quality of life of families of patients: A UK cross‐sectional study. Diabetes Obesity and Metabolism. 27(2). 652–662. 1 indexed citations
7.
Lingvay, Ildiko, Andrei‐Mircea Catarig, Jack Lawson, et al.. (2022). An Indirect Comparison of Basal Insulin Plus Once-Weekly Semaglutide and Fully Optimised Basal–Bolus Insulin in Type 2 Diabetes. Diabetes Therapy. 14(1). 123–137. 1 indexed citations
8.
9.
10.
Evans, Marc, et al.. (2022). The challenges and pitfalls of incorporating evidence from cardiovascular outcomes trials in health economic modelling of type 2 diabetes. Diabetes Obesity and Metabolism. 25(3). 639–648. 5 indexed citations
11.
Strain, W. David, Angharad R. Morgan, & Marc Evans. (2021). The Value of Insulin Degludec in Frail Older Adults with Type 2 Diabetes. Diabetes Therapy. 12(11). 2817–2826. 3 indexed citations
12.
Shiri, Tinevimbo, Marc Evans, Carla Talarico, et al.. (2021). Vaccinating Adolescents and Children Significantly Reduces COVID-19 Morbidity and Mortality across All Ages: A Population-Based Modeling Study Using the UK as an Example. Vaccines. 9(10). 1180–1180. 16 indexed citations
13.
Harris, Stewart B., Martin J. Abrahamson, Antonio Ceriello, et al.. (2020). Clinical Considerations When Initiating and Titrating Insulin Degludec/Liraglutide (IDegLira) in People with Type 2 Diabetes. Drugs. 80(2). 147–165. 17 indexed citations
14.
Bain, Stephen C., et al.. (2019). Pharmacological treatment for Type 2 diabetes integrating findings from cardiovascular outcome trials: an expert consensus in the UK. Diabetic Medicine. 36(9). 1063–1071. 4 indexed citations
15.
Baín, Steve, Debbie Hicks, Dipesh Patel, et al.. (2019). SGLT2 Inhibitors: Cardiovascular Benefits Beyond HbA1c—Translating Evidence into Practice. Diabetes Therapy. 10(5). 1595–1622. 37 indexed citations
16.
Gordon, Jason, Phil McEwan, Iskandar Idris, Marc Evans, & Jorge Puelles. (2018). Treatment choice, medication adherence and glycemic efficacy in people with type 2 diabetes: a UK clinical practice database study. BMJ Open Diabetes Research & Care. 6(1). e000512–e000512. 40 indexed citations
17.
Currie, Craig J., Mark Peyrot, Christopher Ll. Morgan, et al.. (2012). The impact of treatment non-compliance on mortality in people with type 1 diabetes. Journal of Diabetes and its Complications. 27(3). 219–223. 49 indexed citations
18.
Currie, Craig J., Mark Peyrot, Christopher Ll. Morgan, et al.. (2012). The Impact of Treatment Noncompliance on Mortality in People With Type 2 Diabetes. Diabetes Care. 35(6). 1279–1284. 205 indexed citations
19.
Evans, Marc. (2011). Total lipid management and residual risk: beyond statin therapy. British Journal of Hospital Medicine. 72(3). 132–136. 2 indexed citations
20.
DeYoung, D. W., et al.. (1977). Preputial reconstruction for phimosis and infantile penis. Journal of the American Animal Hospital Association. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Richard J. MacIsaac Breakdown of academic impact, for papers by Dario Pitocco Breakdown of academic impact, for papers by Stefan Franzén Breakdown of academic impact, for papers by Frederik Persson Breakdown of academic impact, for papers by Samuel S. Engel Breakdown of academic impact, for papers by David S.H. Bell Breakdown of academic impact, for papers by Anna Norhammar Breakdown of academic impact, for papers by Tsuyoshi Watanabe Breakdown of academic impact, for papers by Enrique Z. Fisman Breakdown of academic impact, for papers by Eugene Manley
Rankless by CCL
2026